SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-24-004689
Filing Date
2024-08-12
Accepted
2024-08-12 14:38:54
Documents
44
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20240630_10q.htm   iXBRL 10-Q 722766
2 EXHIBIT 31.1 ex_708677.htm EX-31.1 13797
3 EXHIBIT 31.2 ex_708678.htm EX-31.2 13741
4 EXHIBIT 32.1 ex_708679.htm EX-32.1 10492
  Complete submission text file 0001171843-24-004689.txt   3366298

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20240630.xsd EX-101.SCH 26359
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20240630_def.xml EX-101.DEF 197474
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20240630_lab.xml EX-101.LAB 198323
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20240630_pre.xml EX-101.PRE 218682
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20240630_cal.xml EX-101.CAL 24981
47 EXTRACTED XBRL INSTANCE DOCUMENT xbit20240630_10q_htm.xml XML 415385
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 241196252
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)